A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer
Clinical trial NCT06561607 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06561607
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2027-01-01
- Enrollment
- 542
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.